Outcome and Prognostic Factors of High-Risk Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

BACKGROUND: Allogeneic transplantation remains one of the best therapies for high-risk acute myeloid leukemia (HR-AML). MATERIAL/METHODS: This study retrospectively analyzed 126 patients with HR-AML after allogeneic hematopoietic stem cell transplantation (allo-HCST). RESULTS: The disease-free survi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Cheng-ying, Chen, Guo-feng, Zhou, Wei, Hou, Cheng, Wang, Xiao-kai, Wang, Fei-yan, Yang, Nan, Wang, Li, Fang, Shu, Luo, Lan, Guan, Li-xun, Zhang, Ran, Liu, Yu-chen, Dou, Li-ping, Gao, Chun-ji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580866/
https://www.ncbi.nlm.nih.gov/pubmed/31171762
http://dx.doi.org/10.12659/AOT.915381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580866/
https://www.ncbi.nlm.nih.gov/pubmed/31171762
http://dx.doi.org/10.12659/AOT.915381

Ejemplares similares